1. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995; 333:1600–1607.
Article
2. Stitt VJ. Stevens-Johnson syndrome: a review of the literature. J Natl Med Assoc. 106; 80:104.
3. Kim CK, Kim SW, Kim JS, Koh YY, Cohen AH, Deterding RR, et al. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest. 2001; 120:1101–1106.
Article
4. Yatsunami J, Nakanishi Y, Matsuki H, Wakamatsu K, Takayama K, Kawasaki M, et al. Chronic bronchobronchiolitis obliterans associated with Stevens-Johnson syndrome. Intern Med. 1995; 34:772–775.
Article
5. Tsunoda N, Iwanaga T, Saito T, Kitamura S, Saito K. Rapidly progressive bronchiolitis obliterans associated with Stevens-Johnson syndrome. Chest. 1990; 98:243–245.
Article
6. Date H, Sano Y, Aoe M, Goto K, Tedoriya T, Sano S, et al. Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome. J Thorac Cardiovasc Surg. 2002; 123:389–391.
Article
7. Sugino K, Hebisawa A, Uekusa T, Hatanaka K, Abe H, Homma S. Bronchiolitis obliterans associated with Stevens-Johnson Syndrome: histopathological bronchial reconstruction of the whole lung and immunohistochemical study. Diagn Pathol. 2013; 8:134.
Article
8. Shah AP, Xu H, Sime PJ, Trawick DR. Severe airflow obstruction and eosinophilic lung disease after Stevens-Johnson syndrome. Eur Respir J. 2006; 28:1276–1279.
Article
9. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med. 2003; 168:121–125.
Article
10. Sugino K, Kimura K, Sano G, Kato N, Takagi K, Tsuchiya K, et al. [An autopsy case of obliterative bronchiolitis associated with Stevens-Johnson syndrome]. Nihon Kokyuki Gakkai Zasshi. 2006; 44:511–516.